These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8244821)

  • 41. Persistence of self-renewing leukemia cell progenitors during remission in children with B-precursor acute lymphoblastic leukemia.
    Estrov Z; Ouspenskaia MV; Felix EA; McClain KL; Lee MS; Harris D; Pinkel DP; Zipf TF
    Leukemia; 1994 Jan; 8(1):46-52. PubMed ID: 8289497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma.
    Bradstock K; Bianchi A; Makrynikola V; Filshie R; Gottlieb D
    Leukemia; 1996 May; 10(5):813-20. PubMed ID: 8656676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.
    Synold TW; Relling MV; Boyett JM; Rivera GK; Sandlund JT; Mahmoud H; Crist WM; Pui CH; Evans WE
    J Clin Invest; 1994 Nov; 94(5):1996-2001. PubMed ID: 7525652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
    Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiosensitivity, repair capacity, and stem cell fraction in human soft tissue tumors: an in vitro study using multicellular spheroids and the colony assay.
    Stuschke M; Budach V; Klaes W; Sack H
    Int J Radiat Oncol Biol Phys; 1992; 23(1):69-80. PubMed ID: 1572832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD117/CD34 expression in leukemic blasts.
    Wells SJ; Bray RA; Stempora LL; Farhi DC
    Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
    Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer.
    Tam KF; Ng TY; Liu SS; Tsang PC; Kwong PW; Ngan HY
    Gynecol Oncol; 2005 Mar; 96(3):765-70. PubMed ID: 15721424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
    Hongo T; Yamada S; Yajima S; Watanabe C; Fujii Y; Kawasaki H; Yazaki M; Hanada R; Horikoshi Y
    Int J Hematol; 1999 Dec; 70(4):268-77. PubMed ID: 10643153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease.
    Göker E; Lin JT; Trippett T; Elisseyeff Y; Tong WP; Niedzwiecki D; Tan C; Steinherz P; Schweitzer BI; Bertino JR
    Leukemia; 1993 Jul; 7(7):1000-4. PubMed ID: 7686600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
    Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
    Ozsahin M; Belkacémi Y; Pène F; Laporte J; Rio B; Leblond V; Korbas D; Touboul E; Gorin NC; Schlienger M; Laugier A
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):71-7. PubMed ID: 12118567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis.
    Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Int J Cancer; 1992 May; 51(2):213-7. PubMed ID: 1568789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of immunophenotype with cerebrospinal fluid involvement in childhood B-lineage acute lymphoblastic leukemia.
    Donskoy E; Tausche F; Altman A; Quinn J; Goldschneider I
    Am J Clin Pathol; 1997 May; 107(5):608-16. PubMed ID: 9128275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leptin receptor in childhood acute leukemias.
    Gorska E; Popko K; Wasik M
    Adv Exp Med Biol; 2013; 756():155-61. PubMed ID: 22836631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
    Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia.
    Wasserman R; Galili N; Ito Y; Silber JH; Reichard BA; Shane S; Womer RB; Lange B; Rovera G
    J Clin Oncol; 1992 Dec; 10(12):1879-88. PubMed ID: 1453203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
    Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of Lymphoid Progenitor Cell Assays for a More Detailed Analysis of the Cytogenetic Changes Occurring During Clonal Evolution in Acute Lymphoblastic Leukemia.
    Uckun FM; Heerema NA
    Leuk Lymphoma; 1990; 2(1-2):1-16. PubMed ID: 27456567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.